Business Description
Embla Medical hf
ISIN : IS0000000040
Compare
Compare
Traded in other countries / regions
EMBLA.DenmarkOSSFF.USA0FIW.UK IPO Date
2016-03-29Description
Embla Medical hf is a provider of prosthetics and bracing and supports solutions; FIOR & GENTZ, an innovative developer of neuro orthotics; and College Park, creators of custom-built prosthetic solutions for people of all activity levels..
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.69 | |||||
| Debt-to-EBITDA | 3.22 | |||||
| Interest Coverage | 4.94 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.32 | |||||
| Beneish M-Score | -2.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.9 | |||||
| 3-Year EBITDA Growth Rate | 23 | |||||
| 3-Year EPS without NRI Growth Rate | 119.9 | |||||
| 3-Year FCF Growth Rate | -5 | |||||
| 3-Year Book Growth Rate | 11.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 95.66 | |||||
| 9-Day RSI | 87.96 | |||||
| 14-Day RSI | 85.64 | |||||
| 3-1 Month Momentum % | 14.09 | |||||
| 6-1 Month Momentum % | 19.44 | |||||
| 12-1 Month Momentum % | 40.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.99 | |||||
| Quick Ratio | 1.26 | |||||
| Cash Ratio | 0.4 | |||||
| Days Inventory | 163.06 | |||||
| Days Sales Outstanding | 56.13 | |||||
| Days Payable | 37.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -1.92 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.02 | |||||
| Operating Margin % | 12.51 | |||||
| Net Margin % | 8.21 | |||||
| FCF Margin % | 8.26 | |||||
| ROE % | 9.43 | |||||
| ROA % | 4.64 | |||||
| ROIC % | 5.94 | |||||
| 3-Year ROIIC % | 12.82 | |||||
| ROC (Joel Greenblatt) % | 31.46 | |||||
| ROCE % | 8.7 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.94 | |||||
| PE Ratio without NRI | 31.94 | |||||
| Shiller PE Ratio | 32.34 | |||||
| Price-to-Owner-Earnings | 24.14 | |||||
| PEG Ratio | 11.01 | |||||
| PS Ratio | 2.7 | |||||
| PB Ratio | 2.92 | |||||
| Price-to-Free-Cash-Flow | 32.82 | |||||
| Price-to-Operating-Cash-Flow | 20.5 | |||||
| EV-to-EBIT | 24.22 | |||||
| EV-to-EBITDA | 16.28 | |||||
| EV-to-Revenue | 3.2 | |||||
| EV-to-FCF | 39.43 | |||||
| Price-to-GF-Value | 1.02 | |||||
| Price-to-Projected-FCF | 1.82 | |||||
| Price-to-DCF (Earnings Based) | 1.98 | |||||
| Price-to-DCF (FCF Based) | 1.99 | |||||
| Price-to-Median-PS-Value | 0.79 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.75 | |||||
| Earnings Yield (Greenblatt) % | 4.13 | |||||
| FCF Yield % | 3.11 | |||||
| Forward Rate of Return (Yacktman) % | 8.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:OSSFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Embla Medical hf Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 840.304 | ||
| EPS (TTM) ($) | 0.162 | ||
| Beta | 0.46 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.39 | ||
| Volatility % | 18.64 | ||
| 14-Day RSI | 85.64 | ||
| 14-Day ATR ($) | 0.012003 | ||
| 20-Day SMA ($) | 5.11075 | ||
| 12-1 Month Momentum % | 40.5 | ||
| 52-Week Range ($) | 3.63 - 5.175 | ||
| Shares Outstanding (Mil) | 426.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Embla Medical hf Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Embla Medical hf Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Embla Medical hf Frequently Asked Questions
What is Embla Medical hf(OSSFF)'s stock price today?
The current price of OSSFF is $5.18. The 52 week high of OSSFF is $5.18 and 52 week low is $3.63.
When is next earnings date of Embla Medical hf(OSSFF)?
The next earnings date of Embla Medical hf(OSSFF) is 2025-02-05.
Does Embla Medical hf(OSSFF) pay dividends? If so, how much?
Embla Medical hf(OSSFF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers